Delphine BADINAND
MD
-
Onco-radiotherapist at the Timone Hospital
APHM
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
#clinicHave a look on our testimonies
MI COMMUNITY
The thrust of MI is the ability of Marseille researchers, clinicians and industrials to play as a team.
Hervé BRAILLY
Innate Pharma
MI COMMUNITY
MI should enable us to accelerate discovery, enhance our treatment options and offer more innovative options to our patients through current clinical trials and those of the future.
Fabrice BARLESI
AP-HM, AMU
MI COMMUNITY
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
Nicolas SCHLEINITZ
AP-HM, AMU
MI COMMUNITY
As such, we are involved in the Marseille immunology biotope
Michel MANCIS
Protisvalor
MI AND YOU Show
your commitment to MI
your commitment to MI